Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2006 | |
| Sales | 361 | 1,728 | 1,396 | 1,404 | 0 |
| Cost of Goods | 26 | 244 | 364 | 168 | N/A |
| Gross Profit | 335 | 1,484 | 1,032 | 1,236 | N/A |
| Operating Expenses | 10,461 | 14,287 | 12,641 | 8,067 | 0 |
| Operating Income | -10,100 | -12,559 | -11,245 | -6,663 | N/A |
| Interest Expense | 404 | 0 | 0 | 0 | 0 |
| Other Income | -622 | 323 | 3,514 | 26 | 0 |
| Pre-tax Income | -11,126 | -12,236 | -7,731 | -6,637 | 0 |
| Income Tax | -150 | 148 | N/A | N/A | N/A |
| Net Income Continuous | -10,976 | -12,384 | -7,731 | -6,637 | N/A |
| Minority Interests | -111 | -230 | -229 | -57 | N/A |
| Net Income | $-10,865 | $-12,154 | $-7,502 | $-6,580 | $N/A |
| EPS Basic Total Ops | -10.21 | -11.62 | -7.39 | -7.39 | N/A |
| EPS Basic Continuous Ops | -9.86 | -11.70 | -7.80 | -7.63 | N/A |
| EPS Basic Discontinuous Ops | -0.35 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -10.21 | -11.62 | -7.39 | -7.39 | N/A |
| EPS Diluted Continuous Ops | -9.86 | -11.70 | -7.80 | -7.63 | N/A |
| EPS Diluted Discontinuous Ops | -0.35 | N/A | N/A | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -10.21 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-8,358 | $-11,554 | $-10,710 | $-5,964 | $N/A |